Literature DB >> 24293452

Association between respiratory prescribing, air pollution and deprivation, in primary health care.

Eleni Sofianopoulou1, Stephen P Rushton, Peter J Diggle, Tanja Pless-Mulloli.   

Abstract

BACKGROUND: We investigated the association between respiratory prescribing, air quality and deprivation in primary health care. Most previous studies have used data from secondary and tertiary care to quantify air pollution effects on exacerbations of asthma and chronic obstructive pulmonary disease (COPD). However, these outcomes capture patients who suffer from relatively severe symptoms.
METHODS: This is a population-based ecological study. We analysed respiratory medication (salbutamol) prescribed monthly by 63 primary care practices, UK. Firstly, we captured the area-wide seasonal variation in prescribing. Then, using the area-wide variation in prescribing as an offset, we built a mixed-effects model to assess the remaining variation in relation to air quality and demographic variables.
RESULTS: An increase of 10 μg/m(3) in ambient PM10 was associated with an increase of 1% (95% CI: 0.1-2%) in salbutamol prescribing. An increase of 1 SD in income and employment deprivation was associated with an increase of 20.5% (95% CI: 8.8-33.4%) and 14.7% (95% CI: 4.3-26.2%) in salbutamol prescribing rate, respectively.
CONCLUSIONS: The study provides evidence that monthly respiratory prescribing in primary care is a useful indicator of the extent to which air pollution exacerbates asthma and COPD symptoms. Respiratory prescribing was higher on deprived populations.

Entities:  

Keywords:  COPD; air pollution; asthma; deprivation; prescribing; primary health care

Mesh:

Substances:

Year:  2013        PMID: 24293452     DOI: 10.1093/pubmed/fdt107

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  9 in total

1.  Spatio-temporal associations of air pollutant concentrations, GP respiratory consultations and respiratory inhaler prescriptions: a 5-year study of primary care in the borough of Lambeth, South London.

Authors:  Mark Ashworth; Antonis Analitis; David Whitney; Evangelia Samoli; Sofia Zafeiratou; Richard Atkinson; Konstantina Dimakopoulou; Sean Beavers; Joel Schwartz; Klea Katsouyanni
Journal:  Environ Health       Date:  2021-05-07       Impact factor: 5.984

2.  Health care utilization and expenditures in persons receiving social assistance in 2012: evidence from Switzerland.

Authors:  Oliver Reich; Felix Wolffers; Andri Signorell; Eva Blozik
Journal:  Glob J Health Sci       Date:  2014-12-16

Review 3.  Defining and targeting health disparities in chronic obstructive pulmonary disease.

Authors:  Roy A Pleasants; Isaretta L Riley; David M Mannino
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-10-04

4.  Investigating trends in asthma and COPD through multiple data sources: A small area study.

Authors:  Areti Boulieri; Anna Hansell; Marta Blangiardo
Journal:  Spat Spatiotemporal Epidemiol       Date:  2016-06-11

5.  Modeling Seasonal and Spatiotemporal Variation: The Example of Respiratory Prescribing.

Authors:  Eleni Sofianopoulou; Tanja Pless-Mulloli; Stephen Rushton; Peter J Diggle
Journal:  Am J Epidemiol       Date:  2017-07-01       Impact factor: 4.897

6.  PrAna: an R package to calculate and visualize England NHS primary care prescribing data.

Authors:  Kishore Kumar Jagadeesan; James Grant; Sue Griffin; Ruth Barden; Barbara Kasprzyk-Hordern
Journal:  BMC Med Inform Decis Mak       Date:  2022-01-06       Impact factor: 2.796

7.  Eupafolin nanoparticles protect HaCaT keratinocytes from particulate matter-induced inflammation and oxidative stress.

Authors:  Zih-Chan Lin; Chiang-Wen Lee; Ming-Horng Tsai; Horng-Huey Ko; Jia-You Fang; Yao-Chang Chiang; Chan-Jung Liang; Lee-Fen Hsu; Stephen Chu-Sung Hu; Feng-Lin Yen
Journal:  Int J Nanomedicine       Date:  2016-08-11

8.  Demographic and socioeconomic patterns in healthcare-seeking behaviour for respiratory symptoms in England: a comparison with non-respiratory symptoms and between three healthcare services.

Authors:  Kirsty E Morrison; Felipe J Colón-González; Roger A Morbey; Paul R Hunter; Judith Rutter; Gareth Stuttard; Simon de Lusignan; Alex Yeates; Richard Pebody; Gillian Smith; Alex J Elliot; Iain R Lake
Journal:  BMJ Open       Date:  2020-11-06       Impact factor: 2.692

9.  Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease?

Authors:  Eleni Sofianopoulou; Colin Church; Gerry Coghlan; Luke Howard; Martin Johnson; David G Kiely; Allan Lawrie; James Lordan; Martin R Wilkins; Stephen J Wort; Nicholas W Morrell; Mark R Toshner
Journal:  Eur Respir J       Date:  2020-08-13       Impact factor: 16.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.